index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Cardiomyopathy Homeostasis Liver Invivo Genomic Myotendinous junction Animals Muscle Biology MiARN Dystrophie Musculaire de Duchenne DMD Delivery CD38 Humans Long noncoding RNA Cells LncARN Muscle Strength Dystrophy Molecular docking Inhibitors Clinical trials Activin Receptors Muscle development CTNNB1 Dystrophie musculaire de Becker DHPR α1S Calcium Channels Diseases Duchenne muscular dystrophy Immunoglobulin Fc Fragments/pharmacology Duchenne muscular dystrophy DMD Energy Metabolism/drug effects Hear LncRNA Ex-vivo Multi resolution modeling Exon skipping Becker BMD muscular dystrophy Centronuclear myopathy Dystrophin-EGFP Muscle Muscles/physiopathology Knockout Cardiomyopathie Gene Expression Regulation/drug effects Dystrophie Musculaire de Becker BMD Morphogenesis Muscular Dystrophy Dystrophin central domain Epigenetics Multiresolution modeling Mitochondrial fission Human Umbilical Vein Endothelial Cells DMO Base Sequence NAD+ Mdx mouse Génomique L-Type Calcium Male BMD Gene modifiers Cell Line MES NNOS Mice Allele‐specific silencing therapy Multi exon skipping Gene expression Inbred mdx Cell homeostasis Skeletal muscle CaVβs Dynamin 2 Animal/physiopathology Antisense oligonucleotides Muscular Atrophy Myogenesis Dystrophine Cultured DMD Autophagy CaV subunits Cell Biology Muscular dystrophy LKB1 Becker muscular dystrophy Metabolism Long QT Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Molecular Sequence Data Dystrophin Inbred C57BL Hepatocellular carcinoma Duchenne DMD dystrophy Becker muscular dystrophy BMD Modificateurs de gènes Drp1 Cachexia